Liaoning Chengda BiotechnologyLtd Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Liaoning Chengda BiotechnologyLtd has a total shareholder equity of CN¥9.5B and total debt of CN¥5.1M, which brings its debt-to-equity ratio to 0.05%. Its total assets and total liabilities are CN¥10.0B and CN¥484.0M respectively. Liaoning Chengda BiotechnologyLtd's EBIT is CN¥402.1M making its interest coverage ratio -12.9. It has cash and short-term investments of CN¥5.4B.
Belangrijke informatie
0.05%
Verhouding schuld/eigen vermogen
CN¥5.08m
Schuld
| Rente dekkingsratio | -12.9x |
| Contant | CN¥5.36b |
| Aandelen | CN¥9.55b |
| Totaal verplichtingen | CN¥483.99m |
| Totaal activa | CN¥10.03b |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: 688739's short term assets (CN¥7.1B) exceed its short term liabilities (CN¥379.3M).
Langlopende schulden: 688739's short term assets (CN¥7.1B) exceed its long term liabilities (CN¥104.7M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 688739 has more cash than its total debt.
Schuld verminderen: 688739's debt to equity ratio has increased from 0% to 0.05% over the past 5 years.
Schuldendekking: 688739's debt is well covered by operating cash flow (10346.3%).
Rentedekking: 688739 earns more interest than it pays, so coverage of interest payments is not a concern.